Reliance Pharmacy Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 02-01-2025
- Paid Up Capital ₹ 2.00 M
as on 02-01-2025
- Company Age 30 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Revenue -5.91%
(FY 2018)
- Profit -43.47%
(FY 2018)
- Ebitda 6.55%
(FY 2018)
- Net Worth 6.47%
(FY 2018)
- Total Assets 0.56%
(FY 2018)
About Reliance Pharmacy
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 2.00 M, as per Ministry of Corporate Affairs (MCA) records.
Kalpanaben Shah, Rakesh Shah, Komal Shah, and Three other members serve as directors at the Company.
- CIN/LLPIN
U24231GJ1994PTC021644
- Company No.
021644
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
25 Mar 1994
- Date of AGM
04 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- LocationBaroda, Gujarat
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Reliance Pharmacy?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shaileshkumar Shah  | Managing Director | 25-Mar-1994 | Current |
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Kalpanaben Shah | Whole-Time Director | 05-Apr-1994 | Current |
| Rakesh Shah | Director | 25-Mar-1994 | Current |
| Komal Shah | Director | 05-Apr-1994 | Current |
| Nitaben Shah | Whole-Time Director | 05-Apr-1994 | Current |
| Hareshbhai Shah | Whole-Time Director | 05-Apr-1994 | Current |
Financial Performance of Reliance Pharmacy.
Reliance Pharmacy Pvt Ltd, for the financial year ended 2018, experienced Minor drop in revenue, with a 5.91% decrease. The company also saw a substantial fall in profitability, with a 43.47% decrease in profit. The company's net worth moved up by a moderate rise of 6.47%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Reliance Pharmacy?
In 2018, Reliance Pharmacy had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Multi Fastners Private LimitedActive 34 years 9 monthsRakesh Shah and Shaileshkumar Shah are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Reliance Pharmacy?
Unlock and access historical data on people associated with Reliance Pharmacy, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Reliance Pharmacy, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Reliance Pharmacy's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
